Oasmia’s Lead Product Paccal Vet®-CA1 Presented at the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Oasmia’s Lead Product Paccal Vet®-CA1 Presented at the ACVIM Forum in Nashville on June 4

Uppsala, Sweden, 2014-06-02 09:00 CEST (GLOBE NEWSWIRE) --  

ACVIM Forum är en årlig kongress som arrangeras av American College of Veterinary Internal Medicine och hålls i år den 4-7 juni i Nashville, Tennessee. Det kommer att hållas föredrag och symposier om Paccal Vet-CA1 och Oasmias patenterade teknologi XR-17. Mer information om ACVIM finns på www.acvim.org .

Paccal Vet-CA1 blev tidigare i år villkorligt godkänt för behandling av juvertumörer och skivepitelscancer av den amerikanska läkemedelsmyndigheten FDA. Det är det första veterinärläkemedlet som innehåller paklitaxel, en av de mest använda kemiterapisubstanserna för behandling av en rad olika cancerformer i människor under de senaste 20 åren.

Abbotts Animal Health-division har exklusiva globala distributionsrättigheter för Paccal Vet-CA1, förutom Japan, Ryssland och Oberoende Staters Samfund (OSS).  

Paccal Vet-CA1 tillverkas och levereras av Oasmia.  

Information till redaktionen:  

Om Paccal Vet ® -CA1 (paklitaxel för injektion) Paccal Vet-CA1 är en cancerbehandling som är utvecklad speciellt för hundar. Det är en ny formulering innehållande paklitaxel, en av de mest använda kemoterapeutiska substanserna. Paccal Vet-CA1 är en ny nanopartikulär formulering baserad på Oasmias patenterade hjälpämne XR-17 vilken förbättrar lösligheten för svårlösliga substanser, som t ex paklitaxel, i lämpliga vattenbaserade lösningsmedel. Två prospektiva, blindade och randomiserade studier för att erhålla fullständiga regulatoriska godkännanden i USA, Europa och Kanada ska snart initieras.  

I USA är indikationerna för Paccal Vet-CA1 behandling av opererbar och icke-opererbar skivepitelcancer (en typ av hudcancer) hos hundar som inte tidigare genomgått kemoterapi eller strålningsterapi, samt behandling av icke-opererbar juvercancer i stadierna III, IV eller V hos hundar som inte tidigare genomgått kemoterapi eller strålningsterapi.  

Om Oasmia Pharmaceutical AB (NASDAQ OMX: OASM) Oasmia Pharmaceutical AB utvecklar en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare användningsområden. Produktutvecklingen bygger på egen forskning inom nanoteknik och egna patent. Bolagets aktie är noterad på NASDAQ OMX i Stockholm och på Frankfurt Stock Exchange. www.oasmia.com

         Mikael Widell, Vice President Communications          Mobil: 070-311 99 60          E-post: mikael.widell@oasmia.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 6

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 7

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading
EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 9

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 5

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 7

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading

Top 5 Most Recently Viewed Articles

Diginex and AIKYA Join Forces to Elevate ESG Reporting in Malaysia

Updated Category News Views 132

Diginex and AIKYA Join Forces to Elevate ESG Reporting in Malaysia Diginex Limited (NASDAQ: DGNX), a forward-thinking impact technology company specializing in environmental, social, and governance (ESG) solutions, has teamed up with AIKYA, a prominent AI and big data technology firm, to unveil an innovative ESG reporting platform, diginexESG, in Malaysia. This...

Continue Reading
Meta's Innovative AI and AR Developments Captivate Audiences

Updated Category News Views 486

Meta Platforms Inc. (NASDAQ: META) is charging forward in the tech arena, grabbing investor attention with its recent AI and AR innovations. At the latest Meta Connect event, the company didn't hold back; they unveiled an upgraded AI assistant and mixed-reality headset options that are not just cutting-edge but also easier on the wallet. This reveals a twofold commitment:...

Continue Reading
Akero Therapeutics Showcases Innovations at Healthcare Conference

Updated Category News Views 121

Akero Therapeutics Highlights Future Innovations Akero Therapeutics, Inc. (NASDAQ: AKRO), renowned for its commitment to developing revolutionary therapies for severe metabolic disorders, recently announced that its management team is set to participate in a prestigious healthcare conference. This important event emphasizes the company’s ongoing mission to address...

Continue Reading
Innovative Storage Solutions Unveiled by Silicon Motion

Updated Category News Views 128

Silicon Motion's Participation at Embedded World 2025 Silicon Motion Technology Corporation (NasdaqGS: SIMO), a renowned innovator in NAND flash controllers for solid-state storage, is set to engage industry stakeholders at Embedded World 2025. This exciting event will run from March 11 through March 13, showcasing the company's latest technology advancements in storage...

Continue Reading
Navigating the Market: Key Earnings and Economic Updates

Updated Category News Views 131

Key Highlights to Watch This Week As we look ahead, investors are feeling the pressure as S&P futures have begun to slip. A busy week filled with corporate earnings reports and central bank meetings is on the horizon, which is critical for market movements. The impending U.S. payrolls report is particularly pivotal, as it will serve as a cornerstone for determining the...

Continue Reading